NASDAQ:LABT | Free Cash Flow | Lakewood-Amedex Biotherapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$349,691.00
2025-03-31-$404,089.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income